Coronavirus (COVID-19)
Featured Topics
Lead story
Other featured articles
-
Quantification of Severe Acute Respiratory Syndrome Coronavirus 2 Binding Antibody Levels To Assess Infection and Vaccine-Induced Immunity Using WHO Standards
With hybrid immunity being now common, it is critical to use protocols adapted to high antibody levels to standardize serological results.
Posted in -
Macroeconomic Consequences of the COVID-19 Pandemic
We estimate the economic impacts of COVID-19 in the U.S. using a disaster economic consequence analysis framework implemented by a dynamic computable general equilibrium (CGE) model.
Posted in -
Characteristics and Outcomes of 360 Consecutive COVID-19 Patients Discharged From the Emergency Department With Supplemental Oxygen
Discharge of select COVID-19 patients with supplemental oxygen from the ED may provide a viable alternative to hospitalization, particularly when inpatient capacity is limited.
Posted in -
Can Financial Incentives and Other Nudges Increase COVID-19 Vaccinations Among the Vaccine Hesitant? A Randomized Trial
Cash incentives and nudges did very little to persuade vaccine-hesitant Americans to get the COVID vaccine, according to new USC research
Posted in
About this section
The coronavirus is impacting every aspect of our lives. Schaeffer Center experts are informing the conversation with their analysis on its impact on health, the economy, public policy, and human behavior. To get in contact with our experts, email Stephanie Hedt, Director of Communications, at hedt@usc.edu.
OUR EXPERTS ON COVID-19
MORE WORK RELATED TO COVID-19
-
Impact of the COVID-19 Pandemic on the Kidney Community: Lessons Learned and Future Directions
Researchers investigate the impact of COVID-19 on kidney care.
-
Bringing Back a Mask Mandate in Los Angeles County is Unjustified
Schaeffer Center experts argue in a recent op-ed that Los Angeles County hasn’t met the threshold for a mask mandate.
-
Opioid Overdoses Continue to Kill Americans: Comprehensive Policy Action Needed
The opioid epidemic has only worsened since the onset of the COVID-19 pandemic.
Categorized in Evidence Base -
It’s Time to Let Pharmacists Prescribe COVID-Fighting Pills Like Paxlovid
To reduce hospitalization and death, pharmacists should have the same prescribing abilities as doctors for COVID anti-viral drugs Paxlovid and Lagevrio, USC School of Pharmacy
Dean Vassilios Papadopoulos writes in a new MarketWatch op-ed. -
A Cost-Utility Analysis of Remote Pulse-Oximetry Monitoring of Patients With COVID-19
Since 2020, COVID-19 has infected tens of millions and caused hundreds of thousands of fatalities in the United States. Infection waves lead to increased emergency department utilization and critical care admission for patients with respiratory distress. Although many individuals develop symptoms necessitating a ventilator, some patients with COVID-19 can remain at home to mitigate hospital overcrowding. Remote pulse-oximetry (pulse-ox) monitoring of moderately ill patients with COVID-19 can be used to monitor symptom escalation and trigger hospital visits, as needed.
-
I Wrongly Expected COVID to Fade Last Summer — Here’s What to Expect This Time
After believing the pandemic would be under control by Memorial Day 2021, Schaeffer Center expert Geoffrey Joyce writes why he believes COVID is nowhere near under control.